We are live on ! Find out more
WJA

Williams Jones & Associates Portfolio holdings

AUM $4.82B
1-Year Est. Return 19.95%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+19.95%
3 Year Est. Return
+72.12%
5 Year Est. Return
+86.19%
10 Year Est. Return
AUM
$4.96B
AUM Growth
+$421M
Cap. Flow
-$19.7M
Cap. Flow %
-0.4%
Top 10 Hldgs %
25.51%
Holding
483
New
33
Increased
126
Reduced
181
Closed
29

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$29.5M
2
PYPL icon
PayPal
PYPL
+$19.7M
3
T icon
AT&T
T
+$13.9M
4
FANG icon
Diamondback Energy
FANG
+$13.2M
5
FDX icon
FedEx
FDX
+$9.25M

Top Sells

Rank Stock Value
1
MHK icon
Mohawk Industries
MHK
+$28.9M
2
MU icon
Micron Technology
MU
+$18M
3
ALB icon
Albemarle
ALB
+$14.5M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.1M
5
USB icon
US Bancorp
USB
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Financials 13.79%
3 Healthcare 13.11%
4 Industrials 10.69%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
376
MiMedx Group
MDXG
$633M
$114K ﹤0.01%
18,500
SNDA icon
377
Sonida Senior Living
SNDA
$1.91B
$112K ﹤0.01%
+793
New +$108K
LPG icon
378
Dorian LPG
LPG
$1.96B
$101K ﹤0.01%
+12,700
New +$99K
PETX
379
DELISTED
Aratana Therapeutics, Inc.
PETX
$100K ﹤0.01%
17,045
-2,000
-11% -$9.99K
TK icon
380
Teekay
TK
$985M
$82K ﹤0.01%
12,200
HIX
381
Western Asset High Income Fund II
HIX
$355M
$77K ﹤0.01%
12,085
AST
382
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$39K ﹤0.01%
30,100
IMDX
383
Insight Molecular Diagnostics
IMDX
$156M
$38K ﹤0.01%
751
-13
-2% -$671
RGN
384
DELISTED
REGENERX BIOPHARMACEUTICALS
RGN
$27K ﹤0.01%
150,000
IW
385
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$19K ﹤0.01%
20,000
DXTR
386
DELISTED
Dextera Surgical Inc.
DXTR
$3K ﹤0.01%
+107,154
New +$3K
AAL icon
387
American Airlines Group
AAL
$10.6B
-39,818
Closed -$1.51M
ALB icon
388
Albemarle
ALB
$15.5B
-153,885
Closed -$14.5M
BIDU icon
389
Baidu
BIDU
$37.2B
-1,900
Closed -$462K
CAG icon
390
Conagra Brands
CAG
$7.23B
-7,000
Closed -$250K
CLLS
391
Cellectis
CLLS
$285M
-12,650
Closed -$358K
EXG icon
392
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.06B
-11,243
Closed -$105K
GOGL
393
DELISTED
Golden Ocean Group
GOGL
-11,700
Closed -$101K
GSK icon
394
GSK
GSK
$106B
-7,284
Closed -$367K
LBRDK icon
395
Liberty Broadband Class C
LBRDK
$5.15B
-3,091
Closed -$234K
MHK icon
396
Mohawk Industries
MHK
$9.22B
-134,993
Closed -$28.9M
MU icon
397
Micron Technology
MU
$991B
-342,675
Closed -$18M
SPOT icon
398
Spotify
SPOT
$100B
-1,850
Closed -$311K
STT icon
399
State Street
STT
$50.7B
-3,141
Closed -$292K
TSLA icon
400
Tesla
TSLA
$1.3T
-10,995
Closed -$251K

Similar funds

Williams Jones & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Williams Jones & Associates held 483 positions worth $4.96B, up 9.3% from $4.54B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Williams Jones & Associates's Q3 2018 filing shows 33 new, 126 increased, 181 reduced and 29 closed positions. Its largest new stake was Nutanix: 91,287 shares worth $3.9M. The largest sale was Mohawk Industries, an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Williams Jones & Associates's largest Q3 2018 buy was Nutanix: 91,287 shares worth $3.9M.
  • Williams Jones & Associates added most to Estee Lauder in Q3 2018, an estimated $29.5M increase.
  • Williams Jones & Associates's biggest Q3 2018 reduction was Idexx Laboratories, cutting an estimated $13.1M.
  • Williams Jones & Associates fully exited Mohawk Industries in Q3 2018, selling an estimated $28.9M.
  • Williams Jones & Associates's ten largest holdings make up 26% of its $4.96B portfolio in Q3 2018.
  • Williams Jones & Associates opened 33 new positions and closed 29 in Q3 2018.
  • Williams Jones & Associates's portfolio value rose 9.3% quarter-over-quarter to $4.96B.

Based on Williams Jones & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.